This, in addition to the identification of WT1 as a predictor of acute myeloid leukemia relapse and the fact that its overexpression is related to poor prognosis, has led to the consideration of WT1 as an oncogene [12,13,14,15]. This evidence concerns the gene WT1 and acute myeloid leukemia.